F.D.A. Approves New Treatment for Early Alzheimer’s. Drugs (Pharmaceuticals), Alzheimer's Disease, Clinical Trials, Medicare, Aduhelm (Drug), Food and Drug Administration, Eisai Co Ltd, Biogen Inc, New England Journal of Medicine, your-feed-healthcare, Regulation and Deregulation of Industry